Clinical Trial Update: Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating pegylated interferon for acute hepatitis C virus infection in injection drug users; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Substance-Related Disorders, Hepatitis | Phase 4 | Status: COMPLETED